DICOM PS3.16 2019e - Content Mapping Resource

TID 10022 Radiopharmaceutical Administration Event Data

The Radiopharmaceutical Administration Event conveys the dose and assay and time information of a single radiopharmaceutical event. A Radiopharmaceutical Administration event is one radioactive pharmaceutical administered to a patient.

Type:

Extensible

Order:

Significant

Root:

No

Table TID 10022. Radiopharmaceutical Administration Event Data

NL

Rel with Parent

VT

Concept Name

VM

Req Type

Condition

Value Set Constraint

1

CONTAINER

EV (113502, DCM, "Radiopharmaceutical Administration")

1

M

2

>

CONTAINS

CODE

EV (349358000, SCT, "Radiopharmaceutical agent")

1

M

DCID 25 “Radiopharmaceuticals”

DCID 4021 “PET Radiopharmaceutical”

3

>>

HAS PROPERTIES

CODE

EV (89457008, SCT, "Radionuclide")

1

M

DCID 18 “Isotopes in Radiopharmaceuticals”

DCID 4020 “PET Radionuclide”

4

>>

HAS PROPERTIES

NUM

EV (304283002, SCT, "Radionuclide Half Life")

1

M

UNITS = EV (s, UCUM, "seconds")

5

>

CONTAINS

NUM

EV (123007, DCM, "Radiopharmaceutical Specific Activity")

1

U

UNITS = EV (Bq/mmol, UCUM, "Bq/mmol")

6

>

CONTAINS

UIDREF

EV (113503, DCM, "Radiopharmaceutical Administration Event UID")

1

M

7

>

CONTAINS

CODE

EV (113505, DCM, "Intravenous Extravasation Symptoms")

1-n

U

DCID 10043 “Intravenous Extravasation Symptoms”

8

>

CONTAINS

NUM

EV (113506, DCM, "Estimated Extravasation Activity")

1

U

UNITS = EV(%, UCUM, "percent")

9

>

CONTAINS

DATETIME

EV (123003, DCM, "Radiopharmaceutical Start DateTime")

1

M

10

>

CONTAINS

DATETIME

EV (123004, DCM, "Radiopharmaceutical Stop DateTime")

1

U

11

>

CONTAINS

NUM

EV (113507, DCM, "Administered activity")

1

M

UNITS = EV (MBq, UCUM, "MBq")

12

>

CONTAINS

NUM

EV (123005, DCM, "Radiopharmaceutical Volume")

1

U

UNITS = EV (cm3, UCUM, "cm3")

13

>

CONTAINS

NUM

EV (113508, DCM, "Pre-Administration Measured Activity")

1

U

UNITS = EV (MBq, UCUM, "MBq")

14

>>

HAS OBS CONTEXT

CODE

EV (113540, DCM, "Activity Measurement Device")

1

U

DCID 10041 “Source of Radioisotope Activity Information”

15

>>

HAS OBS CONTEXT

INCLUDE

DTID 1002 “Observer Context”

1-n

U

16

>

CONTAINS

NUM

EV (113509, DCM, "Post-Administration Measured Activity")

1

U

UNITS = EV (MBq, UCUM, "MBq")

17

>>

HAS OBS CONTEXT

CODE

EV (113540, DCM, "Activity Measurement Device")

1

U

DCID 10041 “Source of Radioisotope Activity Information”

18

>>

HAS OBS CONTEXT

INCLUDE

DTID 1002 “Observer Context”

1-n

U

19

>

CONTAINS

INCLUDE

DTID 10023 “Organ Dose”

1-n

U

20

>

CONTAINS

CODE

EV (410675002, SCT, "Route of administration")

1

M

BCID 11 “Route of Administration”

21

>>

HAS PROPERTIES

CODE

EV (272737002, SCT, "Site of")

1

MC

IF Row 20 equals (47625008, SCT, "Intravenous route") or (78421000, SCT, "Intramuscular route")

DCID 3746 “Percutaneous Entry Site”

22

>>>

HAS CONCEPT MOD

CODE

EV (272741003, SCT, "Laterality")

1

MC

IF Row 21 has laterality

DCID 244 “Laterality”

23

>

CONTAINS

INCLUDE

DTID 1020 “Person Participant”

1-n

M

$PersonProcedureRole = EV (113851, DCM, "Irradiation Administering")

24

>

CONTAINS

CODE

EV (121147, DCM, "Billing Code(s) ")

1-n

U

25

>

CONTAINS

CODE

EV (113510, DCM, "Drug Product Identifier")

1-n

U

26

>

CONTAINS

TEXT

EV (111529, DCM, "Brand Name")

1

U

27

>

CONTAINS

TEXT

EV (113511, DCM, "Radiopharmaceutical Dispense Unit Identifier")

1

U

28

>>

CONTAINS

TEXT

EV (113512, DCM, "Radiopharmaceutical Lot Identifier")

1-n

U

29

>>

CONTAINS

TEXT

EV (113513, DCM, "Reagent Vial Identifier")

1-n

U

30

>>

CONTAINS

TEXT

EV (113514, DCM, "Radionuclide Identifier")

1-n

U

31

>

CONTAINS

TEXT

EV (113516, DCM, "Prescription Identifier")

1

U

32

>

CONTAINS

TEXT

EV (121106, DCM, "Comment")

1

U


Content Item Descriptions

Row 4

The value of Half-life that was used for computing the decay of the administered radiopharmaceutical. It is not intended for use by the receiver for any further computation.

Row 5

Activity per unit mass of the radiopharmaceutical at Radiopharmaceutical Start Time

Row 6

Unique identification of a single radiopharmaceutical administration event.

Row 8

The estimated percentage of administered activity lost at the injection site. The estimation includes extravasation, paravenous administration and leakage at the injection site.

Row 9

The time the radiopharmaceutical was administered to the patient for imaging purposes.

Row 11

Total amount of radioactivity administered to the patient at Radiopharmaceutical Start Time. It is a computed field from the TID 10022 Pre-Administration Measured Activity Row 13, TID 10022 Post-Administration Measured Activity Row 17, Radionuclide Half Life Row 4 and Radiopharmaceutical Start Time Row 9.

Does not include estimated extravasation activity.

Rows 13, 16

Observation DateTime (0040,A032) shall be used to record when the measurement was taken.

Row 23

Identifies the person administering the product.

Row 24

The billing codes for the preparation and administration of the radiopharmaceutical. It does not include performance and interpretation of the imaging.

Row 25

Registered drug establishment code for the product. A coding scheme example is NDC, WHO-DDE or RxNorm. Multiple entries can be used for equivalent drug product codes.

Row 27

The human readable identification of the specific radiopharmaceutical quantity (dose) administered to the patient.

Row 28

Identifies the vial, batch or lot number from which the individual radiopharmaceutical quantity (dose) was produced. Row 27 the Radiopharmaceutical Identifier records the identification for each individual dose.

Row 29

Identifies the lot or unit serial number for the reagent component for the radiopharmaceutical identified in row 27.

Row 30

Identifies the lot or unit serial number for the radionuclide component for the radiopharmaceutical identified in row 27.

DICOM PS3.16 2019e - Content Mapping Resource